Table of Contents

company-logo

PuraPharm Corporation Limited, an investment holding company, researches, develops, produces, and sells concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally. It operates through five segments: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, Clinics, and Plantation. The company offers over the counter health products under the PuraGold, Haveron, Oncozac, and Immuzac names. It also provides Chinese medicine clinic management system for general clinic management; and operates Chinese medicine clinics under the Nong's name that provide Chinese medicine services and concentrated Chinese medicine granules products. In addition, the company engages in the plantation and trading of raw Chinese herbs; and manufacture and sale of traditional Chinese medicine decoction pieces. Further, it provides modernized Chinese medicine services; and Chinese medical diagnostic services. The company sells its products to hospitals, healthcare institutions, and medicine practitioners, as well as operates an online store. It operates 43 Nong's clinics in Hong Kong and 1 Nong's clinic in Guangxi, China. The company was founded in 1998 and is headquartered in Tai Po, Hong Kong.

PuraPharm Dividend Announcement

• PuraPharm announced a annually dividend of HK$0.02 per ordinary share which will be made payable on 2017-06-23. Ex dividend date: 2017-05-31
• PuraPharm's trailing twelve-month (TTM) dividend yield is -%

PuraPharm Dividend History

Ex-Div dateDividend amountDividend typePay date
2017-05-31HK$0.02annually2017-06-23
2016-05-19HK$0.08annually

PuraPharm Dividend per year

PuraPharm Dividend Yield

PuraPharm current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing PuraPharm stock? Use our calculator to estimate your expected dividend yield:

PuraPharm Financial Ratios

P/E ratio-2.90
PEG ratio-0.03
P/B ratio1.94
ROE-61.40%
Payout ratio0.00%
Current ratio0.60
Quick ratio0.31
Cash Ratio0.04

PuraPharm Dividend FAQ

Does PuraPharm stock pay dividends?
PuraPharm does not currently pay dividends to its shareholders.
Has PuraPharm ever paid a dividend?
No, PuraPharm has no a history of paying dividends to its shareholders. PuraPharm is not known for its dividend payments.
Why doesn't PuraPharm pay dividends?
There are several potential reasons why PuraPharm would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will PuraPharm ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While PuraPharm has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is PuraPharm a dividend aristocrat?
PuraPharm is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is PuraPharm a dividend king?
PuraPharm is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is PuraPharm a dividend stock?
No, PuraPharm is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy PuraPharm stocks?
To buy PuraPharm you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy PuraPharm stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.